Literature DB >> 21190736

The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice.

Philippe Georgel1, Mirjana Radosavljevic, Cécile Macquin, Seiamak Bahram.   

Abstract

As opposed to the well established role of MHC-linked, polymorphic, class I (MHC-I) genes in adaptive immunity, a universal role for non-conventional MHC-I is unknown, thus requiring a case-by-case study. The MHC unlinked, monomorphic, but β₂microglobulin (β₂m)-associated "MHC class I related" MR1 molecule interacts with a semi-invariant TCR. The pathophysiology of this interaction or more importantly of this peculiar MHC-I remains mostly unknown. Recently it was shown that β₂m deficient mice were more susceptible to infection by Klebsiella pneumoniae, a widely spread Gram-negative bacteria that causes diverse and often severe ailments in man. Here we demonstrate, using both an in vivo imaging system and survival tests, the increased susceptibility to K. pneumoniae (but not to several other Gram negative bacteria) of MR1 deficient mice. This is accompanied by a consequent change in body temperature and systemic cytokine profile. Hence MR1 controls K. pneumoniae infection in vivo. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21190736     DOI: 10.1016/j.molimm.2010.12.002

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  105 in total

1.  Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection.

Authors:  Wei-Jen Chua; Steven M Truscott; Christopher S Eickhoff; Azra Blazevic; Daniel F Hoft; Ted H Hansen
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 2.  MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?

Authors:  Stanislas Mondot; Pierre Boudinot; Olivier Lantz
Journal:  Immunogenetics       Date:  2016-07-08       Impact factor: 2.846

3.  Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines.

Authors:  Joana Dias; Edwin Leeansyah; Johan K Sandberg
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

Review 4.  The role of mucosal-associated invariant T cells in infectious diseases.

Authors:  Emily B Wong; Thumbi Ndung'u; Victoria O Kasprowicz
Journal:  Immunology       Date:  2016-10-26       Impact factor: 7.397

5.  Recipient mucosal-associated invariant T cells control GVHD within the colon.

Authors:  Antiopi Varelias; Mark D Bunting; Kate L Ormerod; Motoko Koyama; Stuart D Olver; Jasmin Straube; Rachel D Kuns; Renee J Robb; Andrea S Henden; Leanne Cooper; Nancy Lachner; Kate H Gartlan; Olivier Lantz; Lars Kjer-Nielsen; Jeffrey Yw Mak; David P Fairlie; Andrew D Clouston; James McCluskey; Jamie Rossjohn; Steven W Lane; Philip Hugenholtz; Geoffrey R Hill
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

6.  MAITs onstage in mice and men with three acts for development.

Authors:  Nadine Hartmann; Mitchell Kronenberg
Journal:  Immunol Cell Biol       Date:  2016-11-08       Impact factor: 5.126

7.  Do Mucosa-associated Invariant T Cells Checkmate Streptococcus pneumoniae?

Authors:  Prabir Ray; Anuradha Ray
Journal:  Am J Respir Cell Mol Biol       Date:  2018-06       Impact factor: 6.914

8.  Mucosal associated invariant T cells: don't forget your vitamins.

Authors:  Mary H Young; Laurent Gapin
Journal:  Cell Res       Date:  2012-12-04       Impact factor: 25.617

Review 9.  Co-dependents: MR1-restricted MAIT cells and their antimicrobial function.

Authors:  Marielle C Gold; David M Lewinsohn
Journal:  Nat Rev Microbiol       Date:  2012-11-26       Impact factor: 60.633

10.  Characterization of major histocompatibility complex-related molecule 1 sequence variants in non-human primates.

Authors:  Amy L Ellis-Connell; Nadean M Kannal; Alexis J Balgeman; Shelby L O'Connor
Journal:  Immunogenetics       Date:  2018-10-23       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.